FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

30767211000001104: Magdose 160mg tablets (TriOn Pharma Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 14-Oct 2015. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
94160801000001119 Magdose 160mg tablets (TriOn Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
94160901000001113 Magdose 160mg tablets (TriOn Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Magdose 160mg tablets (TriOn Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Magdose 160mg tablets (TriOn Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Magdose 160mg tablets (TriOn Pharma Ltd) Is a Magnesium oxide 160mg tablets true Inferred relationship Existential restriction modifier
Magdose 160mg tablets (TriOn Pharma Ltd) Has active ingredient Magnesium oxide true Inferred relationship Existential restriction modifier
Magdose 160mg tablets (TriOn Pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Magdose 160mg tablets (TriOn Pharma Ltd) Has specific active ingredient Magnesium oxide true Inferred relationship Existential restriction modifier
Magdose 160mg tablets (TriOn Pharma Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Magdose 160mg tablets (TriOn Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Magdose 160mg tablets (TriOn Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Magdose 160mg tablets (TriOn Pharma Ltd) VMP non-availability indicator Re-introduced true Inferred relationship Existential restriction modifier
Magdose 160mg tablets (TriOn Pharma Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Magdose 160mg tablets (TriOn Pharma Ltd) 30 tablet Has AMP True Magdose 160mg tablets (TriOn Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start